ライフサイエンスコーパス: hold promise for

1 Treatments targeting ALT may hold promise for a broadly applicable therapeutic modali

2 These results hold promise for a new generation of bistable, ultrahigh

3 organic) multication lead halide perovskites hold promise for a new generation of easily processable

4 The latter hold promise for a variety of applications, such as ener

5 This phenomenon holds promise for a new generation of capacitors capable

6 al of modern condensed-matter physics, which holds promise for a new generation of electronic/photoni

7 n of epitopes by similar HLA class I alleles holds promise for a universal T-cell-based HIV-1 vaccine

8 One-dimensional conductive particle assembly holds promise for a variety of practical applications, i

9 of circulating, tumor-derived nucleic acids hold promise for addressing the challenge of developing

10 mage and deleterious molecular perturbations holds promise for advancing clinical applications.

11 ide detection of intraventricular hemorrhage holds promise for advancing individual care, targeted th

12 des a further indication that TAML catalysis holds promise for advancing water treatment.

13 Thus, neutralization of PTHrP might hold promise for ameliorating cancer cachexia and improv

14 ng the Bcl-2/Bcl-xL-Beclin 1 interaction may hold promise for ameliorating hypercapnia-induced immuno

15 Furthermore, our mAb discovery strategy holds promise for application to other bacterial pathoge

16 Nanolasers hold promise for applications including integrated photo

17 t construction of truly de novo biocatalysts holds promise for applications in chemical and biochemic

18 truct biological matter from the molecule up holds promise for applications ranging from smart materi

19 Exploiting this spin dependency holds promise for artificial photosynthetic systems requ

20 reflected chemical pollution gradients, thus holding promise for assessment of relative contributions

21 regulatory T cell (Treg)-based immunotherapy holds promise for autoimmune diseases.

22 istently equivalent to embryonic stem cells, holding promise for autologous cell replacement therapy.

23 new approach for autoantibody detection and holds promise for being used for patient stratification

24 understanding of such vesiculation processes holds promise for better elucidation of human physiology

25 orks under behaving conditions, our approach holds promise for better understanding of healthy and ab

26 This discovery holds promise for better understanding the normal physio

27 neration of biosensor based detection tools, holds promise for biological science studies.

28 CTCs hold promise for cancer diagnosis and prognosis and to i

29 of tumor cells to chemotherapeutic drugs may hold promise for cancer treatment.

30 sical activity components suggests that they hold promise for childhood obesity prevention worldwide.

31 erated compared to Goldmann applanation, and holds promise for clinic and home tonometry in children.

32 With recent clinical approval, epothilones hold promise for clinical use after CNS injury.

33 Modulation of RA signaling also holds promise for clinical HSC expansion, a prerequisite

34 The concept holds promise for clinically relevant materials capable

35 and mesenchymal elements to cancer modeling holds promise for combining the accurate multilineage di

36 cal halophytes whose edible succulent shoots hold promise for commercial production in saline water.

37 The method holds promise for commercial and regulatory residue anal

38 These models hold promise for complex neurological diseases such as A

39 n multiferroic and magnetoelectric materials holds promise for conceptually novel electronic devices.

40 boosting Treg function in the clinical phase hold promise for controlling a lesion that is an importa

41 using renewable sources of electrical energy holds promise for converting CO2 to fuels and chemicals.

42 De novo protein design holds promise for creating small stable proteins with sh

43 s study indicates that peroxymonosulfate may hold promise for decontamination of prion-contaminated s

44 This strategy may hold promise for decreasing the shortage of donor lungs.

45 ion studies to rare variants, these findings hold promise for defining the pathogenesis of brain diso

46 terization of ASD risk genes in mouse models holds promise for defining relevant cellular mechanisms

47 Allosteric drug development holds promise for delivering medicines that are more sel

48 s with intraplaque hemorrhage and ultimately holds promise for detection of high-risk plaques in pati

49 w insight into mechanisms of vaccination and holds promise for developing better vaccines.

50 tes appears to phenocopy cancer cells, which holds promise for developing common therapeutics against

51 egulation in different psychiatric disorders holds promise for developing more targeted, and hopefull

52 with a chemical scaffold distinct from these holds promise for developing peripherally active CB1 inv

53 rative and cell cycle-related functions, and hold promise for development of novel therapeutic approa

54 ms, a process known as singlet fission (SF), holds promise for development of solar cells with enhanc

55 ients with LETM, and study of this layer may hold promise for differentiating between NMO and MS.

56 Gas-phase studies of isolated gold clusters hold promise for disentangling these problems.

57 operties in all-inorganic halide perovskites hold promise for diverse applications such as phononic a

58 ed to as "enterotypes" or "community types", holds promise for drastically improving personalized med

59 and trafficking and mechanotransduction, and holds promise for drug and biomarker screening.

60 he HCV glycoproteins and SR-BI may therefore hold promise for effective control of HCV dissemination.

61 as a new two-dimensional (2D) material that holds promise for electronic and photonic technologies.

62 Targeting these pathological interactions holds promise for eliminating minimal residual disease i

63 ysis of contemporary and resurrected enzymes holds promise for elucidating the origins and activities

64 Lithium-ion-conducting solid electrolytes hold promise for enabling high-energy battery chemistrie

65 ets of sequence-homogenized domains that may hold promise for engineering efforts since they exhibit

66 with histone deacetylase inhibitors (HDACis) holds promise for enhancing cancer immune therapy.

67 It holds promise for enhancing the completeness and societa

68 moval of various HMIs in aqueous samples and holds promise for environmental and biomedical applicati

69 s cobalamin-catalysed organic reactions that hold promise for environmentally friendly cobalt catalys

70 ore, orthologous esk1 kak double mutants may hold promise for ethanol production in crop plants.

71 atorial approaches targeting the Raf pathway hold promise for even more substantial clinical benefits

72 This experimental platform holds promise for exploring exotic physics in fractional

73 of ADDSs that spare hemostatic fibrin clots hold promise for extending the utility of ATAs in the ma

74 PCV13 vaccines hold promise for further nonsusceptibility reductions.

75 ess, and this new hydrogel-driven FO process holds promise for further development for practical appl

76 ain, demonstrated in anaesthetized rats, and hold promise for future in vivo studies in animal models

77 for efficient treatment remain, these trials hold promise for future phase III clinical trials.

78 t the levels set by European legislation and holds promise for future adaptation to include other myc

79 Understanding nitrogen metabolism in plants holds promise for future agricultural improvements.

80 rs with high and low EGFR expression in vivo holds promise for future clinical translation.

81 The tunable binary citrem/SPC nanoplatform holds promise for future development of hemocompatible a

82 ng of colloidal semiconductor nanostructures holds promise for future device concepts in optoelectron

83 perimental mouse model of MPE, a result that holds promise for future efficient therapies against the

84 e, and perhaps D-cycloserine and rapastinel, holds promise for future glutamate-modulating strategies

85 Renal sympathetic denervation holds promise for future indications in hypertension and

86 Electronic detection holds promise for future miniaturized in-situ applicatio

87 compatible with large-scale integration and holds promise for future spintronic devices for informat

88 robustness has applications in metrology and holds promise for future uses in quantum computing.

89 While challenges still exist, this approach holds promise for gaining new insights into host-pathoge

90 Antisense oligonucleotides (ASOs) hold promise for gene-specific knockdown in diseases tha

91 njection of biodegradable nanoparticles (NP) holds promise for gene therapy and drug delivery to the

92 as9 delivery by adeno-associated virus (AAV) holds promise for gene therapy but faces critical barrie

93 facilitates functional genomic research and holds promise for gene therapy.

94 Stem cell therapy once held promise for generating large quantities of neurons

95 stinction, selective antifibrotic agents may hold promise for HF with a preserved EF.

96 Novel therapies hold promise for high-risk smoldering multiple myeloma (

97 tIDS holds promise for high-efficacy personalized neuromodula

98 trap instruments onto optofluidic platforms holds promise for high-throughput lab-on-a-chip applicat

99 t technology paired with digital PCR (ddPCR) holds promise for highly precise, absolute nucleic acid

100 in patients with a high-risk profile and may hold promise for identification of vulnerable plaque.

101 Our methods hold promise for identifying and addressing sources of b

102 These functional responses hold promise for identifying important sites for cathete

103 physical techniques, and screening libraries hold promise for identifying suitable agents that could

104 Functional magnetic resonance imaging (fMRI) holds promise for identifying objective measures of pain

105 ing geographical and environmental gradients holds promise for identifying such mechanisms.

106 advances in experimental closed-loop systems hold promise for improved clinical benefit in patients w

107 a new class of LTA4 hydrolase inhibitor that holds promise for improved anti-inflammatory properties.

108 mics, microRNA, proteomics, and metabolomics holds promise for improved biomarkers.

109 Bimetallic, nanostructured materials hold promise for improving catalyst activity and selecti

110 e final Phase 3 of the 1000 Genomes Project, hold promise for improving imputation accuracy in geneti

111 highlighting processes warranting study that hold promise for improving mechanistic understanding of

112 Adaptive decoding methods hold promise for improving neuroprosthetic performance i

113 ions that take a systemic approach to reform hold promise for improving PD effectiveness.

114 Recently, emerging imaging techniques hold promise for improving sensitivity of endoscopic sur

115 ble immunoassays, are simple to perform, and hold promise for improving the specificity and feasibili

116 Novel diagnostic tests hold promise for improving tuberculosis (TB) control, bu

117 Digital technology holds promise for improving access to, and quality of, m

118 Modeling these findings holds promise for improving CRT outcomes.

119 iate immune rejection using RNA interference holds promise for improving islet graft resistance to da

120 The PCMH holds promise for improving the experiences of patients

121 esearch on neuroimaging and pharmacogenetics holds promise for improving treatment for neuropsychiatr

122 he induced pluripotent stem (iPS) cell field holds promise for in vitro disease modeling.

123 induced neurons by direct lineage conversion holds promise for in vitro modelling of sporadic Alzheim

124 Although diffusion tensor imaging holds promise for in vivo characterization of white matt

125 Although these mechanisms hold promise for increasing quality and reducing costs,

126 BACKGROUND AND AIMS: Proteomics holds promise for individualizing cancer treatment.

127 Molecular biomarkers hold promise for inferring rates of key metabolic activi

128 uality two-dimensional chalcogenide crystals hold promise for innovations of next-generation photodet

129 ation, this reciprocal transmission approach holds promise for integration within compact optical sys

130 transcriptome, and RNA interference studies hold promise for interpreting the complex suite of genes

131 This methodology may hold promise for large cetaceans in the wild for which r

132 in that the much shorter optical wavelength holds promise for large-scale integration.

133 manipulation of miR-29b and its target genes holds promise for limiting AAA disease progression and p

134 ompacted mucus penetrating DNA nanoparticles hold promise for lung gene therapy.

135 he mammalian target of rapamycin pathway may hold promise for malformation-associated epilepsy.

136 second harmonic of an Nd:YAG laser (532 nm), hold promise for manipulating and interrogating biologic

137 Integrating DNA delivery systems hold promise for many applications including treatment o

138 smaller building blocks such as DNA and RNA hold promise for many applications, including sensing an

139 Personalized medicines hold promise for many diseases.

140 They thus hold promise for metastasis diagnosis, image-guided surg

141 These data suggest that the MYOM3 fragments hold promise for minimally invasive assessment of experi

142 ve haplotype diversity at the rye Sr50 locus holds promise for mining effective resistance genes.

143 production of MCAEs from renewable resources holds promise for mitigating dependence on fossil hydroc

144 enitor cells from pluripotent stem cells and holds promise for modelling haematopoietic disease in hu

145 l protein functions in a reversible fashion, hold promise for modulating intracellular signaling netw

146 cilizumab (anti-IL-6 receptor [IL-6R]) which holds promise for modulating multiple immune pathways re

147 lecular genetics and leukemic transformation holds promise for more precise patient selection for HSC

148 uman induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following injury, but

149 Biosensors with direct electron output hold promise for nearly seamless integration with portab

150 otic resistance, natural products once again hold promise for new antimicrobial therapies, especially

151 These insights may hold promise for new treatments for addiction.

152 lecular basis of age-related memory loss may hold promise for new treatments for cognitive disorders.

153 ilizing activity of pseudolaric acid B (PAB) holds promise for new anticancer agents.

154 rates molecular and systems biology of GPCRs holds promise for new therapeutics and personalized medi

155 Skyrmions hold promise for next-generation magnetic storage as the

156 lization of versatile electronic devices and holds promise for next-generation (opto)electronics.

157 y integrated within a larger-bandgap matrix, holds promise for novel electronic and optoelectronic pr

158 ding of natural mineralization processes and holds promise for novel materials design.

159 d aggregated Abeta42 species, this candidate holds promise for novel preclinical AD imaging and thera

160 s mechanism in disease and how its targeting holds promise for novel therapeutics.

161 n and recovery on subnanogram samples of DNA holds promise for on-chip genomics applications includin

162 findings here suggest that the FSC platform holds promise for optimization of anti-cancer combinatio

163 vely affects osteochondral tissue repair and holds promise for osteochondral tissue engineering appli

164 ey competences in sustainability science and hold promises for other sectors as well.

165 This process holds promise for other applications like catalysis and

166 f treatment of graft-versus-host disease and holds promise for other diseases characterized by inflam

167 etasurfaces are planar optical elements that hold promise for overcoming the limitations of refractiv

168 castration-resistant prostate cancer (CRPC), holds promise for overcoming the challenge of treating C

169 This approach holds promise for patients suffering from genetic diseas

170 The results hold promise for polysaccharide solubilization under mil

171 of normal NCDPs in FECD-affected endothelium holds promise for potential autologous cell therapies.

172 mage data is an active area of research that holds promise for precision medicine, early assessment o

173 f forward and reserve isomerization pathways holds promise for predictably controlling responses of p

174 ction models estimated from sub-chronic data hold promise for predicting long-term carcinogenicity an

175 hat therapeutic strategies targeting A2B ARs hold promise for preventing adipose tissue inflammation

176 c drugs, and they suggest that sound therapy holds promise for preventing hearing loss in patients re

177 , and strategies to target these cells might hold promise for prevention or treatment of allergic ast

178 ers in conjunction with in-depth phenotyping holds promise for providing insights into the pathophysi

179 Structural neuroimaging holds promise for providing objective biomarkers for dis

180 Stool holds promise for PTB diagnosis in HIV-infected children

181 s, which suggests that copper phthalocyanine holds promise for quantum information processing, and th

182 Microscopic swimming devices hold promise for radically new applications in lab-on-a-

183 hese results, involving a simple PHE device, hold promise for realizing programmable logic elements i

184 PRL-targeted therapy may hold promise for reducing the burden of liver cancer in

185 A brief psychosocial prevention program holds promise for reducing the 1-year incidence of anxie

186 The P particle vaccine holds promise for reducing the disease burden and mortal

187 gineering clinically relevant cells in vitro holds promise for regenerative medicine, but most protoc

188 ological agent that can selectively kill SCs holds promise for rejuvenating tissue stem cells and ext

189 insight to the optical emission physics and holds promise for remote sensing techniques employing no

190 st for hydrogen evolution in acidic solution holds promise for replacing scarce and expensive platinu

191 inally, we discuss genomic technologies that hold promise for resolving questions regarding the evolu

192 ellectual disability and autistic behaviors, holds promise for revealing the molecular basis for thes

193 Artificial muscles hold promise for safe and powerful actuation for myriad

194 Although solution-based exfoliation methods hold promise for scalable production of these materials,

195 The observed speed-pH dependence holds promise for sensitive pH measurements in extreme a

196 e method for sub-surface tomographic imaging holds promise for several applications in semiconductor

197 ting the FGFBP1 and TGF-beta1 signaling axis holds promise for slowing age- and disease-related degen

198 ular, crystalline, and porous materials that hold promise for storage and transport of chemical cargo

199 These results hold promise for studies of dynamics and disorder in man

200 In vitro methods for interneuron generation hold promise for studying human cellular and functional

201 ance to public health, this imaging approach holds promise for studying cardiac-specific mechanisms o

202 Although CPMs hold promise for supporting sex-specific decision making

203 selective electrocatalysts for CO2 reduction hold promise for sustainable fuel production.

204 nd designed with additional functionalities, holding promise for system integration.

205 ogy, multi-target pharmacological strategies hold promise for tackling disease-related networks.

206 Our study holds promise for targeted therapies to the Snord116 loc

207 raordinary specificity of NiV-G for ephrinB2 holds promise for targeting specific ephrinB2(+) populat

208 Epigenome-wide association studies (EWAS) hold promise for the detection of new regulatory mechani

209 eously assemble multiple DNA parts, and they hold promise for the development and optimization of met

210 These results hold promise for the development of an enantioselective

211 al and ADME profile of this corrector series hold promise for the development of more efficacious com

212 These insights hold promise for the development of new diagnostic tests

213 Thus, these classes of MT-stabilizers hold promise for the development of orally active, CNS-d

214 tivation provide clues into pathogenesis and hold promise for the development of point-of-care monito

215 tigen assay, NMP22, ImmunoCyt, and UroVysion hold promise for the early detection of aggressive uroth

216 hich target specific cytokines and pathways, hold promise for the future.

217 by which HPV induces genomic instability and hold promise for the identification of drug targets.

218 ostgenomic technologies, such investigations hold promise for the identification of new clinical inte

219 chemical cells (DS-PECs) for water splitting hold promise for the large-scale storage of solar energy

220 The findings hold promise for the likely influence of federal CF&B re

221 These biomarkers hold promise for the prediction of in situ rates of resp

222 the inflammatory and reparative response may hold promise for the prevention of postinfarction heart

223 tation in chronic HCV patients, and may even hold promise for the prevention of virus rebound during

224 ipulating the biosynthesis of these peptides hold promise for the remediation of soils and groundwate

225 y with data-driven and mechanistic modeling, hold promise for the systematic interrogation of these c

226 that posaconazole-loading of leukocytes may hold promise for the therapy of IPA.

227 al that brain-penetrant MT-stabilizing drugs hold promise for the treatment of AD and related tauopat

228 discovery of positive ASIC1a modulators may hold promise for the treatment of anxiety disorders.

229 target of rapamycin (PI3K/AKT/mTOR) pathway hold promise for the treatment of breast cancer, but res

230 Oncolytic viruses hold promise for the treatment of cancer, but their inte

231 Efforts to induce physiological angiogenesis hold promise for the treatment of diabetic microvascular

232 ent of isoform-specific PI3K inhibitors that hold promise for the treatment of hematopoietic malignan

233 ts suggest that tyrosine-mutant AAV8 vectors hold promise for the treatment of individuals with MERTK

234 ctivity or increasing PAF-mediated signaling hold promise for the treatment of intestinal malignancie

235 to joint inflammation, and anti-DEK aptamers hold promise for the treatment of JIA and other types of

236 h as efflux pumps, are under development and hold promise for the treatment of multidrug resistant in

237 gamma-Secretase inhibitors hold promise for the treatment of patients with NOTCH1 m

238 Thus, targeting of TCR-related events may hold promise for the treatment of TFH-derived lymphomas.

239 tion and suggest that MEK/ERK inhibitors may hold promise for the treatment of type 2 diabetes.

240 ive approaches using muscle progenitor cells hold promises for the treatment of many forms of muscle

241 ion of 6.42% (n=5); consequently, the method holds promise for the analysis of commercial fruit juice

242 uld be applicable to many infectious agents, holds promise for the construction of vaccines that can

243 nsformations.Plasmon-enhanced photocatalysis holds promise for the control of chemical reactions.

244 topoietic stem cell (HSC)-based gene therapy holds promise for the cure of many diseases.

245 understanding of NAb repertoire development holds promise for the design of both biological diagnost

246 The 3D X-ray structure of these DNA crystals holds promise for the design of new structural motifs to

247 Imaging the DDR holds promise for the detection of preneoplasia and as a

248 s in the pathogenesis of intestinal fibrosis holds promise for the development of effective antifibro

249 and/or desensitization/inactivation of nAChR holds promise for the development of new antidepressants

250 therapy), making this regulation unique, and holds promise for the development of novel alternative/c

251 RNA-protein interaction in hantaviruses and holds promise for the development of the first anti-hant

252 thin the highly conserved IRES subdomain IIa holds promise for the development of unique anti-HCV dru

253 The fluorescence polarization assay holds promise for the discovery of potent small-molecule

254 hus, controlled manipulation of this pathway holds promise for the expansion of beta cells in patient

255 This precision spectroscopic technique holds promise for the future development of high-through

256 Laser-generated-focused ultrasound (LGFU) holds promise for the high-precision ultrasound therapy

257 Computational enzyme design holds promise for the production of renewable fuels, dru

258 essful attempt at engineering heme stability holds promise for the production of stable Hb-based bloo

259 ain pseudospin coherence at room temperature holds promise for the realization of new classical and q

260 Thus blue light holds promise for the sterilization of clinical surfaces

261 therapy with ATM and microtubule inhibitors holds promise for the treatment of alveolar rhabdomyosar

262 clearance of these cells by senolytic agents holds promise for the treatment of atherosclerosis.

263 doptive immunotherapy using cultured T cells holds promise for the treatment of cancer and infectious

264 cell immunity, and autologous DC vaccination holds promise for the treatment of cancers and chronic i

265 Gemcitabine/docetaxel with doxorubicin holds promise for the treatment of LMS.

266 Although adoptive T-cell therapy holds promise for the treatment of many cancers, its cli

267 Gene therapy holds promise for the treatment of many pathologies of t

268 ure of harmless, health-associated bacteria, holds promise for the treatment of patients with severe

269 Antisense oligonucleotides (AONs) hold promise for therapeutic correction of many genetic

270 Targeting DC functional properties may hold promise for therapeutic intervention in NASH.

271 This therapeutic strategy holds promise for this AML patient subgroup in future cl

272 ions used for prevention in older adults may hold promise for those in middle age.

273 They hold promise for transforming the current technologies i

274 Kerr frequency combs hold promise for transforming these lab-scale oscillator

275 entification and isolation of these lineages hold promise for translational medicine aimed at in vivo

276 Although stem cells hold promise for treating degenerative diseases by 'seed

277 Parasitic helminths hold promise for treating inflammatory disorders, so we

278 d that existing interventions targeting them hold promise for treating neuropsychiatric disorders.

279 Targeting the JAK pathway holds promise for treating age-related dysfunction.

280 Nucleic acid editing holds promise for treating genetic disease, particularly

281 and suggests that reprogramming this circuit holds promise for treating opiate addiction.

282 Psychosocial therapy holds promise for treating patients with dual diagnosis.

283 prevent memory loss in Ts65Dn mice, and may hold promise for treatment in individuals with DS and de

284 naling pathways, and as such, JAK inhibitors hold promise for treatment of autoimmune disorders, incl

285 ese cases is yet missing, but is believed to hold promise for treatment of cancer and prevention of h

286 using anti-IL-1beta monotherapy, these data hold promise for treatment of type 1 diabetic patients w

287 NF-related apoptosis-inducing ligand (TRAIL) holds promise for treatment of cancer due to its ability

288 These data suggest that targeting TLR7 holds promise for treatment of human pancreatic cancer.

289 st targeting epigenetic chromatin regulators holds promise for treatment of inflammatory and oestroge

290 c organic and physical-inorganic chemistries holds promise for tremendous new opportunities in both a

291 Our open-source framework thus holds promise for turning brain activity mapping efforts

292 hese treatments appear safe for humans, they hold promise for type 1 diabetes intervention.

293 it light long after cessation of excitation, hold promise for ultrasensitive in vivo imaging because

294 In vivo molecular imaging holds promise for understanding the underlying mechanism

295 tion studies (GWASs) have been considered to hold promise for unravelling complex relationships betwe

296 PROs also hold promise for use in evaluating adherence, adverse ef

297 in their electric and magnetic ground states hold promise for use in next-generation memory devices i

298 ce their cooperation with B cells, and which hold promise for vaccine development.

299 Loading viral vectors with cGAMP therefore holds promise for vaccine development.

300 vskite solar cells and lithium-ion batteries hold promise for various potential applications.